Submission Details
| 510(k) Number | K211380 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 04, 2021 |
| Decision Date | July 30, 2021 |
| Days to Decision | 87 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K211380 is an FDA 510(k) clearance for the Elexir, a Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (Class II — Special Controls, product code PCC), submitted by Nu Eyne Co., Ltd. (Seoul, KR). The FDA issued a Cleared decision on July 30, 2021, 87 days after receiving the submission on May 4, 2021. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5891.
| 510(k) Number | K211380 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 04, 2021 |
| Decision Date | July 30, 2021 |
| Days to Decision | 87 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | PCC — Stimulator, Nerve, Electrical, Transcutaneous, For Migraine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5891 |
| Definition | Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin. |